New data from the National Institutes of Health shows that, for all but a few drugs that can cause severe side effects, no fertility medication has an effect on a woman’s fertility.
The research, published in the journal Health Affairs, found that women who take fertility drugs are less likely to have babies in the first year of pregnancy than women who don’t.
The researchers looked at data from more than 1.6 million women, ages 18 to 74, who were tracked from 2010 to 2013 for their fertility treatments.
All women were randomly assigned to receive one of three fertility treatments: three months of the fertility drug Humira, three months plus the treatment of a combination of Humira and a progestin, or the combination of the two treatments.
The three treatments were combined with a two-week placebo period.
The drugs had different effects on a subset of women.
Humira decreased the rate of fertilization by 31% among women who took it, but the fertility rate increased for those who took Humira plus a combination therapy.
For women taking Humira alone, the fertility benefit dropped to 12% of those who were given the combination therapy alone.
The study’s lead author, Sara Reichenbach, an epidemiologist at the National Institute of Child Health and Human Development, said that the findings “demonstrate that there are no significant differences between the three fertility medications” in terms of lowering the rate and reducing a woman from having babies in her first year.
However, the authors noted that other drugs like Humira may have an effect.
“If women have more than one drug, or are more likely to be taking multiple drugs, then this could be important to look at,” Reichenbeach said.
The other drug that did not affect fertility, Humira Plus, has no effect in women taking it alone.
And there were some side effects for some of the drugs.
Humiera Plus caused a slight increase in intrauterine growth restriction (IUGR) for some women who were taking Humiera, but only for the subset who took the combination.
For the majority of women taking the combination, there was no increase in IUGR.
Humiva Plus also decreased a woman who took a combination regimen from having a baby to having a vaginal delivery.
Humicide Plus, on the other hand, has a side effect of a mild headache.
“The side effects are less severe than the side effects that are usually associated with the combination,” said Reichenbel.
She said that more research is needed to determine whether there are differences in the benefits of the three treatments.
Humana is an injectable birth control pill that is approved for use in the United States and Europe.
The Humana Plus is a combination drug that has a higher concentration of the progestins that Humira uses.
But, unlike Humira or Humiraplus, it is not an injectible pill that can be swallowed or injected.
Humans progestogens are absorbed from the skin, not injected into the body.
It can cause an allergic reaction if the injection site is not protected.
It is also not an oral contraceptive and cannot be used as a method of birth control for women with pre-existing conditions like asthma or diabetes.
This makes it less effective as a contraceptive, according to the Centers for Disease Control and Prevention.
However it is still widely used.
The FDA recently updated its guidelines to require that women take the combined contraceptive HumiraPlus and HumiraPro plus at the same time.
Women who have received Humira but don’t take Humira are required to take HumainPro to prevent pregnancy.
This regimen includes Humira.
The National Institutes for Health has provided funding to the study and Reichenach said she is not surprised by the findings.
“What surprised me is that these two drugs have very different effects.
One is a progesterone pill and the other is a hormone contraceptive,” Reichbach said.
“In the case of Humain, it can have very serious side effects in the uterus.
In the case to Humira Pro, it doesn’t have those problems, and there are very few side effects.”
Reichenbeck said the next step for the researchers will be to look into how women’s medications affect fertility.
“It is important that we get more information about how this drug is affecting fertility,” Reischbach said, “and also how it is affecting other reproductive health issues.”